NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Jupiter Bioscience Limited (NSE: JUPITER)
JUPITER Technical Analysis
1
As on N/A JUPITER SHARE Price closed @ N/A and we RECOMMEND N/A for LONG-TERM with Stoploss of N/A & N/A for SHORT-TERM with Stoploss of N/A we also expect STOCK to react on Following IMPORTANT LEVELS. |
JUPITERSHARE Price
Open | N/A | Change | Price | % |
High | N/A | 1 Day | N/A | N/A |
Low | N/A | 1 Week | N/A | N/A |
Close | N/A | 1 Month | N/A | N/A |
Volume | N/A | 1 Year | N/A | N/A |
52 Week High N/A | 52 Week Low N/A |
NSE INDIA Most Active Stocks
IDEA | 7.47 | -5.80% |
YESBANK | 17.77 | -3.58% |
SUZLON | 58.30 | -3.01% |
GTLINFRA | 1.51 | -5.62% |
RPOWER | 41.36 | -6.78% |
IEX | 190.50 | -0.18% |
NMDC | 64.95 | -4.51% |
IDFCFIRSTB | 66.08 | -2.32% |
HCC | 27.26 | 0.04% |
CANBK | 96.53 | -2.88% |
NSE INDIA Top Gainers Stocks
NSE INDIA Top Losers Stocks
JUPITER Daily Charts |
JUPITER Intraday Charts |
Whats New @ Bazaartrend |
JUPITER Free Analysis |
|
JUPITER Important Levels Intraday
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE | |
RESISTANCE |
JUPITER Target April 2025
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
JUPITER Weekly Target
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
JUPITER Target2025
4th UP Target | |
3rd UP Target | |
2nd UP Target | |
1st UP Target | |
1st DOWN Target | |
2nd DOWN Target | |
3rd DOWN Target | |
4th DOWN Target |
Jupiter Bioscience Limited ( NSE INDIA Symbol : JUPITER )
Sector : Pharmaceuticals - Bulk Drugs and Formulations And Other Stocks in Same Sector
Sector : Pharmaceuticals - Bulk Drugs and Formulations And Other Stocks in Same Sector
JUPITER Synopsis Technicals View
50 Day EMA |
N/A (Short Term) |
N/A | |
100 Day EMA | N/A (Mid Term) | N/A | |
200 Day EMA | N/A (Long Term) | N/A | |
MACD (12 26 9) | N/A | N/A | |
RSI (14) | N/A | N/A | |
MFI (14) | N/A | N/A | |
CCI (20) | N/A | N/A | |
WILLIAM %R (14) | N/A | N/A | |
ADX (14) | N/A | N/A | |
PSAR | N/A | N/A | |
10 Day Avg Volume | N/A |
JUPITER Other Details
Segment | BE | |
Market Capital | 0.00 | |
Sector | Pharmaceuticals - Bulk Drugs and Formulations | |
Industry | ||
Offical website | > echo $website ; ?> |
JUPITER Address
![]() |
N/A |
JUPITER Latest News
JUPITER Business Profile
Jupiter Bioscience (JUPIBIOSC) has business activities focused on peptides, advanced organic chemistry, chiral chemistry and biotechnology. It was established as a private limited company in 1985 and went public in 1995. Earlier known as Jupiter Orga, it got its present name on Feb. 09, 2001.
The ISO 9001:2000 certified company has business operations along the product groups of peptide reagents and protected amino acids, drug intermediates, and specialty and fine chemicals. It manufactures 14 categories of peptide reagents, 6 variety of coupling reagents and over 100 varieties of protected amino acids. Some of the important products in the organic drug intermediate space include Ecpp Alanine, N- Hydroxy and Succinimide among others. In the chiral space, it produces key intermediates used in lisinopril, ramipril and perindropil. Specialty and fine chemicals like methyl resorcinol, 4-chloro resorcinol and methyl resorcinol are produced, which find application in the manufacture of hair dye and as an antimicrobial agent.
The four manufacturing facilities are located at Bidar in Karnataka; Cheriyal, Gaddapotharam and Cherlapally in Andhra Pradesh. The R&D division is located in Cherlapally. The company caters to pharmaceutical companies manufacturing peptide therapeutics and peptide intermediates, biotechnology companies, research-based entities working on new peptide-based therapeutics for cosmetic manufacturers, and chemical manufacturing companies. Apart from manufacturing products, the company provides services such as custom synthesis, process development and scale-up, and contract R&D. It has a strategic alliance with the Clariant group, a global leader in the field of specialty chemicals, for the development of peptides.
Sven Genetech and Jupiter Bioscience Inc. are 100% subsidiaries. Sven Genetech conducts synthesis of peptides including side chain protected amino acids and unnatural amino acids and manufactures nutraceuticals and cosmoceuticals. Jupiter Bioscience Inc, incorporated in USA, caters to the end user market in peptides and peptide components in USA, Europe, Canada and Japan.
The company has reported a standalone sales of Rs 33.28 crore and a Net Profit of Rs 0.4 crore for the quarter ended Sep 2011.
The registered office is located at 24 Kolhar, IDA, Bidar-585401, Karnataka.
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service